Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 3
2018 7
2019 7
2020 10
2021 7
2022 9
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6.
Färber SF, Wurzer A, Reichart F, Beck R, Kessler H, Wester HJ, Notni J. Färber SF, et al. Among authors: wurzer a. ACS Omega. 2018 Feb 28;3(2):2428-2436. doi: 10.1021/acsomega.8b00035. ACS Omega. 2018. PMID: 30023833 Free PMC article.
Dendritic poly-chelator frameworks for multimeric bioconjugation.
Reich D, Wurzer A, Wirtz M, Stiegler V, Spatz P, Pollmann J, Wester HJ, Notni J. Reich D, et al. Among authors: wurzer a. Chem Commun (Camb). 2017 Feb 23;53(17):2586-2589. doi: 10.1039/c6cc10169k. Chem Commun (Camb). 2017. PMID: 28191563
Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide.
Reichart F, Maltsev OV, Kapp TG, Räder AFB, Weinmüller M, Marelli UK, Notni J, Wurzer A, Beck R, Wester HJ, Steiger K, Di Maro S, Di Leva FS, Marinelli L, Nieberler M, Reuning U, Schwaiger M, Kessler H. Reichart F, et al. Among authors: wurzer a. J Med Chem. 2019 Feb 28;62(4):2024-2037. doi: 10.1021/acs.jmedchem.8b01588. Epub 2019 Feb 6. J Med Chem. 2019. PMID: 30657681
Utility of 18F-rhPSMA-7.3 PET for Imaging of Primary Prostate Cancer and Preoperative Efficacy in N-Staging of Unfavorable Intermediate- to Very High-Risk Patients Validated by Histopathology.
Langbein T, Wang H, Rauscher I, Kroenke M, Knorr K, Wurzer A, Schwamborn K, Maurer T, Horn T, Haller B, Wester HJ, Eiber M. Langbein T, et al. Among authors: wurzer a. J Nucl Med. 2022 Sep;63(9):1334-1342. doi: 10.2967/jnumed.121.263440. Epub 2022 Jan 6. J Nucl Med. 2022. PMID: 34992154
32 results